Add to ORKGThe underline neuropathology of Parkinson disease is pleiomorphic and its genetic background diverse. Possibly because of this heterogeneity, no effective disease modifying therapy is available. In this paper we give an overview of the genetics of Parkinson disease and explain how this is relevant for the development of new therapies
AbstractIt is hoped that an understanding of the genetic basis of Parkinson's disease (PD) will lead...
Parkinson's disease is a common neurological disorder where the prevalence increases with age. The d...
Parkinson Disease (PD) is a common neurodegenerative disorder of intricate etiology, caused by progr...
The underline neuropathology of Parkinson disease is pleiomorphic and its genetic background diverse...
The genetic landscape of Parkinson’s disease (PD) is characterised by rare high penetrance pathogeni...
Background: Parkinson’s disease is the second most important neurodegenerative disorder, affecting ...
Parkinson’s disease (PD) is a common neurological movement disorder that mainly affects individuals ...
The identification of genes contributing to Parkinson's disease (PD) has allowed for an improved und...
Parkinson's disease (PD) is a neurodegenerative disorder caused by a complex interplay of genetic an...
Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. The median a...
Breakthroughs in genetics over the last decade have radically advanced our understanding of the etio...
A substantial proportion of risk for Parkinson's disease (PD) is driven by genetics. Progress in und...
Introduction. Advances in sequencing technologies have enabled extensive genetic testing on an indiv...
Research in Parkinson’s disease (PD) genetics has been extremely prolific over the past decade. More...
Parkinson disease (PD) is known as a common progressive neurodegenerative disease which is clinicall...
AbstractIt is hoped that an understanding of the genetic basis of Parkinson's disease (PD) will lead...
Parkinson's disease is a common neurological disorder where the prevalence increases with age. The d...
Parkinson Disease (PD) is a common neurodegenerative disorder of intricate etiology, caused by progr...
The underline neuropathology of Parkinson disease is pleiomorphic and its genetic background diverse...
The genetic landscape of Parkinson’s disease (PD) is characterised by rare high penetrance pathogeni...
Background: Parkinson’s disease is the second most important neurodegenerative disorder, affecting ...
Parkinson’s disease (PD) is a common neurological movement disorder that mainly affects individuals ...
The identification of genes contributing to Parkinson's disease (PD) has allowed for an improved und...
Parkinson's disease (PD) is a neurodegenerative disorder caused by a complex interplay of genetic an...
Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. The median a...
Breakthroughs in genetics over the last decade have radically advanced our understanding of the etio...
A substantial proportion of risk for Parkinson's disease (PD) is driven by genetics. Progress in und...
Introduction. Advances in sequencing technologies have enabled extensive genetic testing on an indiv...
Research in Parkinson’s disease (PD) genetics has been extremely prolific over the past decade. More...
Parkinson disease (PD) is known as a common progressive neurodegenerative disease which is clinicall...
AbstractIt is hoped that an understanding of the genetic basis of Parkinson's disease (PD) will lead...
Parkinson's disease is a common neurological disorder where the prevalence increases with age. The d...
Parkinson Disease (PD) is a common neurodegenerative disorder of intricate etiology, caused by progr...
